Edwards Lifesciences Corporation Maintains Confidence In Financial Guidance For 2026
EW•Reuters brief
Edwards Lifesciences Corporation said it maintains confidence in financial guidance for 2026.
Related News
Apple’s foldable iPhone poses a $1,999 question: Who is it for?
AAPL•
First Breach files Form 3 showing director Robert Charles Brandt stake of 34,247 shares
FBDT•
Canada's Descartes Q2 operating income jumps; revenue slightly beats driven by services growth
DSGX•
Meta Announces Quarterly Cash Dividend
META•
Vingroup highlights green transition, ESG transparency in TIME World’s Best Companies 2026 ranking
VFS•